Cairo – Mubasher: Nile Pharmaceuticals and Chemical Industries (Nile Pharma) has achieved a net profit of EGP 11.29 million over nine months, from July 2018 to March 2019.
Nile Pharma’s financial statements showed a positive turn in the nine-month period against losses valued at EGP 6.7 million incurred during the period from July 2017 to March 2018, the board members announced, according to a bourse disclosure on Sunday.
During the period ended on 31 March 2019, Revenues grew by 41% to EGP 503.21 million, compared to EGP 357 million in the corresponding period a year ago.
